Medtronic Plc

NYSE: MDT
$86.00
-$1.97 (-2.2%)
Closing Price on November 14, 2024

MDT Articles

24/7 Wall St. has put together a preview of Broadcom, Medtronic and some other major companies reporting their quarterly results this week.
Three solid health care ideas featured by RBC are posting good numbers and expanding their product silos in an effort to continue to add new business.
Investors love when companies pay dividends. More specifically, they love companies that are raising their dividends year after year.
The top analyst upgrades, downgrades and initiations seen on Monday morning include Baidu, Caterpillar, GE, Honeywell, Kimberly-Clark, Schlumberger and Southern Energy.
Merrill Lynch has some ideas about how to take advantage of the trends in health care going forward.
Medtronic released its fiscal third-quarter earnings report before the markets opened on Tuesday and shares tumbled.
Medtronic is scheduled to report its fiscal third-quarter financial results before the markets open on Tuesday.
IBM's Watson is not a consumer product, so the selection of Bob Dylan and other the well-know people is out of place, and so is its presence on national TV.
All these Cowen picks offer compelling values for 2016, and all have backed up enough in price for investors to get an outstanding entry point.
Medtronic reported better-than-expected fiscal second-quarter financial results before the markets opened on Thursday.
Medtronic is scheduled to report its fiscal second-quarter financial results after the markets close on Thursday.
Friday's top analyst upgrades, downgrades and initiations include Abbott Labs, BioMarin Pharmaceutical, CBS, Cisco, GameStop, Petrobras, Sirius XM, SunPower and Yelp.
Thursday's top analyst upgrades, downgrades and initiations include Brookdale Senior Living, Dish Network, Groupon, Infinera, Medtronic, Pier 1 Imports, Tupperware and Yum Brands.
A new report from Deutsche Bank makes the case that the selling in health care stocks is way overdone, and the proverbial baby is being tossed out with the bath water.
On Medtronic, Oppenheimer has an Outperform rating and a $86 price target, implying upside of 25% from current prices.